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CPT-11 (irinotecan), the first-line chemotherapy for advanced stage colorectal
cancer, remains inactive in about half of patients (primary chemoresistance) and
almost all initial responders develop secondary resistance after several courses of
treatment (8 months on average). Nude mice bearing HT-29 colon cancer xenografts
were treated with CPT-11 and/or an NF-κB inhibitor for two courses. We confirm
that NF-κB inhibition potentiated CPT-11 anti-tumoural effect after the first course
of treatment. However, tumours grew again at the end of the second course of
treatment, generating resistant tumours. We observed an increase in the basal NF-
κB activation in resistant tumours and in two resistant sublines, either obtained from
resistant HT-29 tumours (HT-29R cells) or generated in vitro (RSN cells). The
decrease of NF-κB activation in HT-29R and RSN cells by stable transfections with
the super-repressor form of IκBα augmented their sensitivity to CPT-11. Comparing
gene expression profiles of HT-29 and HT-29R cells, we identified the
S100A10/Annexin A2 complex and calpain 2 as over-expressed potential NF-κB
inducers. SiRNA silencing of calpain 2 but not of S100A10 and/or annexin A2,
resulted in a decrease in NF-κB activation, an increase in cellular levels of IκBα and
a partial restoration of the CPT-11 sensitivity in both HT-29R and RSN cells,
suggesting that calpain 2-dependent IκBα degradation mediates CPT-11 secondary
resistance. Thus, targeted therapies directed against calpain 2 may represent a
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